Syndecan-4 Enhances Therapeutic Angiogenesis after Hind Limb Ischemia in Mice with Type 2 Diabetes

Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system

(2013) Subhamoy Das et al.   BIOMATERIALS

Economic Costs of Diabetes in the U.S. in 2012

(2013)   DIABETES CARE

Syndecan-4 signaling at a glance

(2013) A. Elfenbein et al.   JOURNAL OF CELL SCIENCE

Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle

(2012) E. Jang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inflammation and wound healing: the role of the macrophage

(2011) Timothy J. Koh et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Peripheral artery disease. Part 2: medical and endovascular treatment

(2011) Mitchell D. Weinberg et al.   Nature Reviews Cardiology

Phase I/IIa Clinical Trial of Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer to Treat Critical Limb Ischemia

(2010) Ryuichi Morishita et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia

(2010) H Shigematsu et al.   GENE THERAPY

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia

(2008) Satoaki Matoba et al.   AMERICAN HEART JOURNAL

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia

(2008) Sigrid Nikol et al.   MOLECULAR THERAPY

Robust flow measurement with multi-exposure speckle imaging

(2008) Ashwin B. Parthasarathy et al.   OPTICS EXPRESS